+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Carpal Tunnel Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767260
  • Report
  • 97 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • AlfaSigma SpA
  • Allergan Plc
  • Arthritis Research UK
  • Bristol-Myers Squibb Co
  • Endo International Plc
  • Nuvo Pharmaceuticals Inc
  • MORE
The global clinical trial report- “2019 Carpal Tunnel Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Carpal Tunnel Syndrome. It presents in-depth analysis of Carpal Tunnel Syndrome clinical trials across markets and companies. The research work is for providing complete understanding into trends in Carpal Tunnel Syndrome.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Carpal Tunnel Syndrome clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Carpal Tunnel Syndrome

The research work is prepared through extensive and continuous research on Carpal Tunnel Syndrome trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Carpal Tunnel Syndrome patients are identified
  • The report includes panorama of Carpal Tunnel Syndrome clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Carpal Tunnel Syndrome clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AlfaSigma SpA
  • Allergan Plc
  • Arthritis Research UK
  • Bristol-Myers Squibb Co
  • Endo International Plc
  • Nuvo Pharmaceuticals Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Carpal Tunnel Syndrome Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Carpal Tunnel Syndrome Clinical Trials by Region
2.2.2 Average Enrollment of Carpal Tunnel Syndrome Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Carpal Tunnel Syndrome Treatment, 2019

3. Region wise Carpal Tunnel Syndrome Clinical Trials
3.1 Asia Pacific Carpal Tunnel Syndrome Clinical Trials by Country
3.2 Europe Carpal Tunnel Syndrome Clinical Trials by Country
3.3 North America Carpal Tunnel Syndrome Clinical Trials by Country
3.4 Middle East and Africa Carpal Tunnel Syndrome Clinical Trials by Country
3.5 South and Central America Carpal Tunnel Syndrome Clinical Trials by Country

4. Carpal Tunnel Syndrome Clinical Trial Trends
4.1 Start Year wise Carpal Tunnel Syndrome Clinical Trials
4.2 Phase wise Carpal Tunnel Syndrome Clinical Trials
4.3 Trial Status wise Carpal Tunnel Syndrome Clinical Trials
4.4 Trial Type wise Carpal Tunnel Syndrome Clinical Trials

5. Carpal Tunnel Syndrome Average Enrollment Trends
5.1 Average Enrollment in Carpal Tunnel Syndrome Trials by Year
5.2 Average Enrollment in Carpal Tunnel Syndrome Trials by Phase
5.3 Average Enrollment in Carpal Tunnel Syndrome Trials by Status
5.4 Average Enrollment in Carpal Tunnel Syndrome Trials by Type of Trial

6. Companies Participating in Carpal Tunnel Syndrome Clinical Trials
6.1 Carpal Tunnel Syndrome Trials by Sponsor Type
6.2 Carpal Tunnel Syndrome Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Carpal Tunnel Syndrome Trials- Phase 1
7.2 Carpal Tunnel Syndrome Trials- Phase 2
7.3 Carpal Tunnel Syndrome Trials- Phase 3
7.4 Carpal Tunnel Syndrome Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Carpal Tunnel Syndrome Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Carpal Tunnel Syndrome Clinical Trials and Enrolment
Figure 5: Europe - Country wise Carpal Tunnel Syndrome Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Carpal Tunnel Syndrome Clinical Trials and Enrolment
Figure 7: North America - Country wise Carpal Tunnel Syndrome Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Carpal Tunnel Syndrome Clinical Trials and Enrolment
Figure 9: Carpal Tunnel Syndrome Clinical Trials by Phase
Figure 10: Carpal Tunnel Syndrome Clinical Trials by Trial Status
Figure 11: Carpal Tunnel Syndrome Clinical Trials by Type
Figure 12: Carpal Tunnel Syndrome Clinical Trials by Sponsor Type
Figure 13: Carpal Tunnel Syndrome Clinical Trials by Leading Sponsors
Figure 14: Carpal Tunnel Syndrome Average Enrollment by Phase
Figure 15: Carpal Tunnel Syndrome Average Enrollment by Trial Status
Figure 16: Carpal Tunnel Syndrome Average Enrollment by Type
Figure 17: Carpal Tunnel Syndrome- Average Enrolment by Type of Sponsors
Figure 18: Carpal Tunnel Syndrome- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Carpal Tunnel Syndrome Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Carpal Tunnel Syndrome Clinical Trials and Enrolment
Table 5: Europe - Country wise Carpal Tunnel Syndrome Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Carpal Tunnel Syndrome Clinical Trials and Enrolment
Table 7: North America - Country wise Carpal Tunnel Syndrome Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Carpal Tunnel Syndrome Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Carpal Tunnel Syndrome Average Enrollment by Phase
Table 15: Carpal Tunnel Syndrome Average Enrollment by Trial Status
Table 16: Carpal Tunnel Syndrome Average Enrollment by Type
Table 17: Carpal Tunnel Syndrome- Average Enrolment by Type of Sponsors
Table 18: Carpal Tunnel Syndrome- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AlfaSigma SpA
  • Allergan Plc
  • Arthritis Research UK
  • Bristol-Myers Squibb Co
  • Charles River Laboratories International Inc
  • Endo International Plc
  • Nippon Zoki Pharmaceutical Co Ltd
  • Nuvo Pharmaceuticals Inc
  • Ono Pharmaceutical Co Ltd
Note: Product cover images may vary from those shown
Adroll
adroll